INSIGHTS ON CLINICAL TRIAL PARTNERING

• How A Biotech Startup Transformed Their Clinical Trial Supply Management

  Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.

• Biopharma Giant Streamlines Infrastructure With Proprietary Software

  Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.

• Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup

  This clip explores why choosing an RTSM partner requires more than fast startup timelines, highlighting how long‑term flexibility and operational durability matter far more once a study is underway.

• How RFI/RFP Optimization Changes The Game

  Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.

• Ethical & Regulatory Considerations For Pediatric Gene Therapy

  5/28/2026

  Understanding risk thresholds, consent requirements, and IRB expectations early can prevent redesign, reduce delays, and improve trial feasibility for vulnerable patient populations

• Optimizing EDC Strategy And Data Collection for a Rare Disease Trial

  6/11/2025

  Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.

• Leading Recruitment With A Strong Alzheimer's Referral Pool

  2/24/2026

  A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.

   

• Breaking Down Early Small Molecule Development

  3/11/2026

  Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  10/21/2025

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.